Snow Capital Management’s Co-Diagnostics CODX Stock Holding History

Snow Capital Management’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.18M	Buy	4,756 +3,045	+178%	+$783K	0.17%	93
2021 Q1	$490K	Buy	+1,711	New	+$683K	0.07%	115

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Snow Capital Management's CODX Position: Q2 2021 in Review

Snow Capital Management increased its Co-Diagnostics (CODX) stake by 178% in Q2 2021, buying an estimated $783K and bringing the position to 4,756 shares worth $1.18M. The position accounts for 0.17% of the portfolio, ranked #93.

Snow Capital Management first reported a position in CODX in Q1 2021 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

Snow Capital Management held 4,756 shares of Co-Diagnostics worth $1.18M as of Q2 2021.
Snow Capital Management bought 3,045 Co-Diagnostics shares in Q2 2021, an estimated $783K.
Co-Diagnostics made up 0.17% of Snow Capital Management's portfolio in Q2 2021, its #93 holding.
Snow Capital Management first reported a position in Co-Diagnostics in Q1 2021 and has held it in 2 quarters since.
88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.